Early pulmonary response to intratracheal instillation of silica (14808607) particles was characterized by bronchoalveolar lavage fluid (BALF) analysis and luminol dependent chemiluminescence (LDCL). Male Fischer-344-rats were intratracheally instilled with 0, 25 or 100mg/kg silica. BALF total protein was significantly increased two fold 2 hours (hr) after treatment at both doses and 2.5 fold after 4hr at the higher exposure. The 4hr total protein level was significantly elevated relative to the 2h level at the 100mg/kg dose. A significant 2.5 fold increase in BALF albumin was observed 4hr after the 100mg/kg dose. BALF gamma-glucuronidase activity was significantly increased two and four fold by 25 and 100mg/kg doses, respectively, 4hr after instillation. BALF lactate- dehydrogenase activity was significantly increased two and six fold by 25 and 100mg/kg silica, respectively, after 4hr. Total BALF cell numbers were significantly increased after 4hr in the 100mg/kg group, with a seven fold increase in neutrophils. The 4hr neutrophil increase represented a significant 4.5 fold increase over the 2hr levels. Significant four and seven fold increases at the 25 and 100mg/kg doses, respectively, were measured in phorbol-myristate- acetate (PMA) stimulated LDCL activity 4hr after instillation. The LDCL activity of unstimulated lung tissue from 100mg/kg treated rats, 4hr after instillation, was significantly six fold greater than 2h posttreatment and four fold greater than controls. Inhibition of PMA stimulated LDCL by superoxide-dismutase was 58.9% and 66.2% for the 25mg/kg, 2 and 4hr posttreatment groups, respectively, and 49.3% and 73.1% for the 100mg/kg 2 and 4hr posttreatment groups, respectively. Inhibition of PMA stimulated LDCL by N-omega-nitro-L-arginine-methyl-ester was 52.3% and 60.2% for the 25mg/kg, 2 and 4hr posttreatment groups, respectively, and 66.6% and 12.1% for the 100mg/kg 2 and 4hr posttreatment groups, respectively. The authors conclude that pulmonary damage is evident within 2hr and inflammation occurs within 4hr of silica exposure.
Michael DiMatteo, Robert C. Byrd Health Sciences Center of West Virginia University, Department of Pharmacology and Toxicology, P.O. Box 9223, Morgantown, WV 26506-9223, USA
CODEN
JTEHD6
CAS No.
14808-60-7
Publication Date
19960101
Document Type
Journal Article
Funding Amount
2937066
Funding Type
Cooperative Agreement
Fiscal Year
1996
Identifying No.
Cooperative-Agreement-Number-U60-CCU-306149
Issue of Publication
1
ISSN
0098-4108
Priority Area
Pulmonary-system-disorders
Source Name
Journal of Toxicology and Environmental Health, Part A: Current Issues
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.